Fulton v. MEDICAL BD. OF CALIFORNIA

183 Cal. App. 4th 1510, 108 Cal. Rptr. 3d 424, 2010 Cal. App. LEXIS 555
CourtCalifornia Court of Appeal
DecidedApril 23, 2010
DocketB215102
StatusPublished
Cited by2 cases

This text of 183 Cal. App. 4th 1510 (Fulton v. MEDICAL BD. OF CALIFORNIA) is published on Counsel Stack Legal Research, covering California Court of Appeal primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Fulton v. MEDICAL BD. OF CALIFORNIA, 183 Cal. App. 4th 1510, 108 Cal. Rptr. 3d 424, 2010 Cal. App. LEXIS 555 (Cal. Ct. App. 2010).

Opinion

Opinion

EPSTEIN, P. J.

Appellant James E. Fulton, Jr., appeals from a judgment denying his claim for declaratory and injunctive relief against respondent, the Medical Board of California (the Board). Appellant was a licensed physician in California before surrendering his license in 2003 to settle disciplinary charges filed by the Board. Afterwards, the Board published disciplinary information about appellant on its Web site, including information about a medical malpractice judgment entered against him, and the surrender, retirement, and indefinite suspension of his licenses to practice medicine in other states. Appellant sued the Board, claiming that because he no longer was licensed in California, he was not a “licensed physician” or a “licensee” under Business and Professions Code section 2027 (and by implication the cross-referenced § 803.1), 1 and therefore the Board was not required to disclose the information. The trial court found the Board acted within its *1513 statutory mandate and denied appellant’s claim. 2 He appeals, arguing the court erred in its interpretation of the statutes. We disagree, and hold that sections 803.1 and 2027 required the Board to publish the information.

FACTUAL AND PROCEDURAL SUMMARY

Following the usual rules on appeal after a trial on the merits, we construe the facts in the light most favorable to the judgment. (Woodman Partners v. Sofa U Love (2001) 94 Cal.App.4th 766, 111 [114 Cal.Rptr.2d 566].)

Appellant was first licensed to practice medicine in California in 1970. Beginning in 1997, California and several other states initiated disciplinary actions against him. In 2002, appellant voluntarily surrendered his California license as part of a stipulated settlement with the Board; the surrender became effective in 2003. Shortly thereafter, the Board posted information on its Web site showing that appellant surrendered his California license in 2003. The same year, the Board changed its disclosure policy about individuals formerly licensed in California. Under its new policy, which remains its policy, information about disciplinary actions undertaken by the Board and in other states, felony convictions, and certain settlements and arbitration awards is available on the Internet. (See fn. 4, post.) The Board posted information about enforcement actions taken against appellant in other states while he was licensed in California, and updated disclosures as out-of-state cases proceeded. The disclosures included the surrender, retirement, and indefinite suspension of appellant’s medical licenses in Florida, New York, and Louisiana, and a malpractice judgment entered against him in Orange County Superior Court. Actions initiated against appellant after he surrendered his California license were not disclosed, including the revocation of his Tennessee license in 2005.

Although appellant was no longer licensed to practice medicine in any state, he continued to work in a field closely related to medicine. Appellant gave three-day lectures in California and elsewhere for a company, Advanced Aesthetics Training Institute, about diseases of the skin, the causes and treatments of acne, and other dermatological topics. Attendees were given certificates signed by appellant as an “M.D.” 3 Appellant’s family had an ownership interest in a company, Vivant Pharmaceuticals (Vivant), that *1514 produced dermatological products which appellant promoted at trade shows in various states, including California. Advertising materials for the products attributed the titles “Dr.” or “M.D.” to appellant, described him as a “Lead Formulating Consultant,” and mentioned his “35 years of experience as a physician.” Vivant’s products were sold to the public through a Web site that described appellant’s medical education, and claimed that he was a “leading researcher, cosmetic surgeon and dermatologist.” Appellant answered questions on the Web site regarding the causes and treatments for skin conditions as “DrJFulton.” The record does not show that the Web site disclosed that appellant was not licensed to practice medicine. An investigator from the Board purchased products from the Web site, which were delivered to California with an embossed inscription of appellant’s signature, “James E. Fulton, M.D.”

Appellant filed this action against the Board in 2008. He alleged that the Board’s disclosures of his disciplinary record caused him to lose work opportunities and suffer “public and private ridicule and embarrassment.” Some of Vivant’s customers called the company and discussed, in an agitated manner, the information posted on the Board’s Web site. While appellant was giving a lecture at a conference in Malaysia, the chairman of the conference received an e-mail referencing the Board’s Web site, with the comment “shame, shame, shame.” Appellant was not invited to subsequent conferences. He sought a declaratory judgment that the Board was not statutorily required to publish the disciplinary information, and an injunction prohibiting the Board from posting any information about him on its Web site. The matter proceeded to trial, and judgment was entered for the Board. This appeal followed.

DISCUSSION

Appellant argues that sections 803.1 and 2027 do not require the Board to “post information regarding disciplinary actions against physicians who are no longer licensed by the State.” Because this claim requires interpretation of sections 803.1 and 2027, we apply a de novo standard of review. (Szold v. Medical Bd. of California (2005) 127 Cal.App.4th 591, 596, fn. 4 [25 Cal.Rptr.3d 665].)

“In construing any statute, ‘ [w] ell-established rules of statutory construction require us to ascertain the intent of the enacting legislative body so that we may adopt the construction that best effectuates the purpose of the law.’ [Citation.] ‘We first examine the words themselves because the statutory language is generally the most reliable indicator of legislative intent. [Citation.] The words of the statute should be given their ordinary and usual meaning and should be construed in their statutory context.’ [Citation.] If the *1515 statutory language is unambiguous, ‘we presume the Legislature meant what it said, and the plain meaning of the statute governs.’ [Citation.]” (Whaley v. Sony Computer Entertainment America, Inc. (2004) 121 Cal.App.4th 479, 484-485 [17 Cal.Rptr.3d 88].) “If, however, the statutory terms are ambiguous, then we may resort to extrinsic sources, including the ostensible objects to be achieved and the legislative history.” (Day v. City of Fontana (2001) 25 Cal.4th 268, 272 [105 Cal.Rptr.2d 457, 19 P.3d 1196].) The Board interprets sections 803.1 and 2027 to require that it disclose enforcement actions that occurred while former licensees were licensed in California, and to correct errors in disclosures. We accord respect and consideration to the Board’s interpretation, but we apply our independent judgment in construing the statutes. (See Yamaha Corp. of America v. State Bd. of Equalization

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
183 Cal. App. 4th 1510, 108 Cal. Rptr. 3d 424, 2010 Cal. App. LEXIS 555, Counsel Stack Legal Research, https://law.counselstack.com/opinion/fulton-v-medical-bd-of-california-calctapp-2010.